Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003816
What this trial is testing

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 361
Not applicableActive Not RecruitingNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT03885830
What this trial is testing

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

Who this might be right for
CML, Chronic PhaseCML (Chronic Myelogenous LeukemiaCML - Philadelphia Chromosome+2 more
UNC Lineberger Comprehensive Cancer Center 45
Post-approval studies (Phase 4)Not Yet RecruitingNCT07839988
What this trial is testing

De-escalation Strategy of Tyrosine Kinase Inhibitors Before Treatment Discontinuation in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia in Chronic Phase
Nanfang Hospital, Southern Medical University 280
Testing effectiveness (Phase 2)Study completedNCT00244829
What this trial is testing

Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002681
What this trial is testing

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Roger Williams Medical Center 25
Early research (Phase 1)Study completedNCT01460498
What this trial is testing

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT02016833
What this trial is testing

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

Who this might be right for
Ovarian Serous AdenocarcinomaUndifferentiated Carcinoma of OvaryCervical Cancer+3 more
PX Biosolutions 15
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00750009
What this trial is testing

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Case Comprehensive Cancer Center 583
Not applicableStudy completedNCT00281814
What this trial is testing

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 36
Early research (Phase 1)Study completedNCT00301093
What this trial is testing

Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Dana-Farber Cancer Institute 3
Early research (Phase 1)WithdrawnNCT00732186
What this trial is testing

Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic
Bristol-Myers Squibb
Not applicableStudy completedNCT00082654
What this trial is testing

Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00093366
What this trial is testing

Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Fred Hutchinson Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT01498445
What this trial is testing

An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 32
Large-scale testing (Phase 3)Ended earlyNCT00519090
What this trial is testing

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia
Novartis Pharmaceuticals 6
Early research (Phase 1)Study completedNCT02129582
What this trial is testing

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaHematologic MalignanciesAcute Lymphocytic Leukemia+8 more
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01167166
What this trial is testing

Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaMyeloproliferative Disease+1 more
Traws Pharma, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00044954
What this trial is testing

Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
University of Texas Southwestern Medical Center
Next Page